Literature DB >> 9630894

ABGEN: a knowledge-based automated approach for antibody structure modeling.

C Mandal1, B D Kingery, J M Anchin, S Subramaniam, D S Linthicum.   

Abstract

Immunoglobulin (Ig) amino acid sequences are highly conserved and often have sequence homology ranging from 70 to 95%. Antigen binding fragments (Fab), variable region fragments (Fv), and single chain Fv (scFv) of more than 50 myeloma proteins and monoclonal antibodies (mAb) have been crystallized and display a high degree of structural similarity. Based on this observation, several homology modeling approaches have been developed for the prediction of Fab and Fv structures prior to their experimental determination. We have extracted features from existing Ig sequences, 44 known Fab and Fv structures to create an automated AntiBody structure GENeration (ABGEN) algorithm for obtaining structural models of antibody fragments. ABGEN utilizes a homology based scaffolding technique, and includes the use of invariant and strictly conserved residues, structural motifs of known Fab, canonical features of hypervariable loops, torsional constraints for residue replacements and key inter-residue interactions. The validity of the ABGEN algorithm has been tested using a five-fold cross validation with the existing Fab structures. Molecular mechanics and dynamics methods have been implemented with ABGEN models to accurately predict two Fab structures of anti-sweetener antibodies prior to crystallographic determinations.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9630894     DOI: 10.1038/nbt0396-323

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  17 in total

1.  Modeling of loops in protein structures.

Authors:  A Fiser; R K Do; A Sali
Journal:  Protein Sci       Date:  2000-09       Impact factor: 6.725

2.  Structural requirements of the major protective antibody to Haemophilus influenzae type b.

Authors:  L Hougs; L Juul; A Svejgaard; T Barington
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  An insight into the active site of a type I DNA topoisomerase from the kinetoplastid protozoan Leishmania donovani.

Authors:  Aditi Das; Chhabinath Mandal; Arindam Dasgupta; Tanushri Sengupta; Hemanta K Majumder
Journal:  Nucleic Acids Res       Date:  2002-02-01       Impact factor: 16.971

Review 4.  How repertoire data are changing antibody science.

Authors:  Claire Marks; Charlotte M Deane
Journal:  J Biol Chem       Date:  2020-05-14       Impact factor: 5.157

5.  Characterization of the ATPase activity of topoisomerase II from Leishmania donovani and identification of residues conferring resistance to etoposide.

Authors:  Tanushri Sengupta; Mandira Mukherjee; Aditi Das; Chhabinath Mandal; Rakhee Das; Tanmoy Mukherjee; Hemanta K Majumder
Journal:  Biochem J       Date:  2005-09-01       Impact factor: 3.857

Review 6.  Structure-based design of immunologically active therapeutic peptides.

Authors:  R Murali; M I Greene
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

7.  Search for fucose binding domains in recently sequenced hypothetical proteins using molecular modeling techniques and structural analysis.

Authors:  Sujata Majumder; Madhumita Patra; Chhabinath Mandal
Journal:  Glycoconj J       Date:  2006-05       Impact factor: 2.916

8.  Detection and characterization of a sialoglycosylated bacterial ABC-type phosphate transporter protein from patients with visceral leishmaniasis.

Authors:  Angana Ghoshal; Sumi Mukhopadhyay; Rodion Demine; Michael Forgber; Saulius Jarmalavicius; Bibhuti Saha; Shyam Sundar; Peter Walden; Chhabinath Mandal; Chitra Mandal
Journal:  Glycoconj J       Date:  2009-01-29       Impact factor: 2.916

9.  Prediction of 3-D structures of fucose-binding proteins and structural analysis of their interaction with ligands.

Authors:  Sujata Majumder; Avik Roy; Chhabinath Mandal
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

10.  Induction of glycosylation in human C-reactive protein under different pathological conditions.

Authors:  Tanusree Das; Asish K Sen; Tore Kempf; Sumit R Pramanik; Chhabinath Mandal; Chitra Mandal
Journal:  Biochem J       Date:  2003-07-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.